Cellectis (CLLS) Reports Q1 EPS of EUR0.23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Cellectis (CLLS) Reports Q1 EPS of EUR0.23
June 9, 2015 5:36 PM EDT
Companies to apply next generation gene editing technology to the
alfalfa seed industry
FRESNO, Calif. & NEW BRIGHTON, Minn.--(BUSINESS WIRE)--
Regulatory News:
S&W Seed Company (Nasdaq: SANW), a leading provider of seed genetics,
production, processing and marketing for the alfalfa seed market, and
Calyxt, Inc., a Minnesota-based company focusing on developing healthier
food products, and a wholly owned subsidiary of Cellectis (Nasdaq: CLLS,
Alternext: ALCLS), today announced they have entered into a
collaboration agreement to research, develop, produce, and commercialize... More
June 9, 2015 5:30 PM EDT
PARIS--(BUSINESS WIRE)--
Regulatory News:
Cellectis (Alternext: ALCLS Nasdaq Global Market: CLLS), in order to
comply with NASDAQ financial practices, is publishing for the first time
its 1st quarter results.
Cellectis previously published consolidated financial statements for the
first six months of 2014 and for the full year 2014. The Company did not
publish financial statements for first half-year and full year 2014.
Cellectis did not have consolidated financial statements for the 1st
and 3rd quarters 2014. Therefore, no comparative 2014 figures
will be presented for 1st and 3rd quarters in
2015. Cellectis will publish full quarterly comparative figures starting
2016.... More
